12月11日，神威药业(02877)盘中上涨5.04%，截至11:09，报10.42元/股，成交487.8万元。
中国神威药业集团有限公司是专注于现代中药研发、生产、销售的大型企业集团，主要操作现代中药新剂型、新产品，着重发展在高速增长的中老年、儿童用药及抗病毒用药的市场。2004年，该公司综合实力跃居全国中成药企业十强，并以清开灵注射液、参麦注射液和心脑清软胶囊成为国内最大生产商，拥有总销售额超过千万元的品种15个，其中3个品种年销售额过亿。
截至2024年中报，神威药业营业总收入20.87亿元、净利润6.26亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.